These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 30803124)

  • 1. Circulating ceruloplasmin, ceruloplasmin-associated genes and the incidence of venous thromboembolism in the Atherosclerosis Risk in Communities study.
    Arenas de Larriva AP; Alonso A; Norby FL; Roetker NS; Folsom AR
    J Thromb Haemost; 2019 May; 17(5):818-826. PubMed ID: 30803124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating ceruloplasmin, ceruloplasmin-associated genes, and the incidence of atrial fibrillation in the atherosclerosis risk in communities study.
    Arenas de Larriva AP; Norby FL; Chen LY; Soliman EZ; Hoogeveen RC; Arking DE; Loehr LR; Alonso A
    Int J Cardiol; 2017 Aug; 241():223-228. PubMed ID: 28427851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ceruloplasmin and heart failure in the Atherosclerosis Risk in Communities study.
    Dadu RT; Dodge R; Nambi V; Virani SS; Hoogeveen RC; Smith NL; Chen F; Pankow JS; Guild C; Tang WH; Boerwinkle E; Hazen SL; Ballantyne CM
    Circ Heart Fail; 2013 Sep; 6(5):936-43. PubMed ID: 23861484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective study of circulating factor XI and incident venous thromboembolism: The Longitudinal Investigation of Thromboembolism Etiology (LITE).
    Folsom AR; Tang W; Roetker NS; Heckbert SR; Cushman M; Pankow JS
    Am J Hematol; 2015 Nov; 90(11):1047-51. PubMed ID: 26260105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atrial fibrillation and venous thromboembolism: evidence of bidirectionality in the Atherosclerosis Risk in Communities Study.
    Lutsey PL; Norby FL; Alonso A; Cushman M; Chen LY; Michos ED; Folsom AR
    J Thromb Haemost; 2018 Apr; 16(4):670-679. PubMed ID: 29431904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Replication of a genetic risk score for venous thromboembolism in whites but not in African Americans.
    Folsom AR; Tang W; Weng LC; Roetker NS; Cushman M; Basu S; Pankow JS
    J Thromb Haemost; 2016 Jan; 14(1):83-8. PubMed ID: 26565658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and genetic association of serum ceruloplasmin with cardiovascular risk.
    Tang WH; Wu Y; Hartiala J; Fan Y; Stewart AF; Roberts R; McPherson R; Fox PL; Allayee H; Hazen SL
    Arterioscler Thromb Vasc Biol; 2012 Feb; 32(2):516-22. PubMed ID: 22075249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lung function, respiratory symptoms and venous thromboembolism risk: the Atherosclerosis Risk in Communities Study.
    Kubota Y; London SJ; Cushman M; Chamberlain AM; Rosamond WD; Heckbert SR; Zakai N; Folsom AR
    J Thromb Haemost; 2016 Dec; 14(12):2394-2401. PubMed ID: 27696765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum uric acid, gout, and venous thromboembolism: The atherosclerosis risk in communities study.
    Kubota Y; McAdams-DeMarco M; Folsom AR
    Thromb Res; 2016 Aug; 144():144-8. PubMed ID: 27337701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Racial and regional differences in venous thromboembolism in the United States in 3 cohorts.
    Zakai NA; McClure LA; Judd SE; Safford MM; Folsom AR; Lutsey PL; Cushman M
    Circulation; 2014 Apr; 129(14):1502-9. PubMed ID: 24508826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C-reactive protein, obesity, and the risk of arterial and venous thrombosis.
    Horvei LD; Grimnes G; Hindberg K; Mathiesen EB; Njølstad I; Wilsgaard T; Brox J; Braekkan SK; Hansen JB
    J Thromb Haemost; 2016 Aug; 14(8):1561-71. PubMed ID: 27208592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum 25-hydroxyvitamin D and risk of venous thromboembolism: the Atherosclerosis Risk in Communities (ARIC) Study.
    Folsom AR; Roetker NS; Rosamond WD; Heckbert SR; Basu S; Cushman M; Lutsey PL
    J Thromb Haemost; 2014 Sep; 12(9):1455-60. PubMed ID: 25039645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective study of plasma D-dimer and incident venous thromboembolism: The Atherosclerosis Risk in Communities (ARIC) Study.
    Folsom AR; Alonso A; George KM; Roetker NS; Tang W; Cushman M
    Thromb Res; 2015 Oct; 136(4):781-5. PubMed ID: 26337932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammation markers and incident venous thromboembolism: the REasons for Geographic And Racial Differences in Stroke (REGARDS) cohort.
    Olson NC; Cushman M; Lutsey PL; McClure LA; Judd S; Tracy RP; Folsom AR; Zakai NA
    J Thromb Haemost; 2014 Dec; 12(12):1993-2001. PubMed ID: 25292154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Taller height as a risk factor for venous thromboembolism: a Mendelian randomization meta-analysis.
    Roetker NS; Armasu SM; Pankow JS; Lutsey PL; Tang W; Rosenberg MA; Palmer TM; MacLehose RF; Heckbert SR; Cushman M; de Andrade M; Folsom AR
    J Thromb Haemost; 2017 Jul; 15(7):1334-1343. PubMed ID: 28445597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycemia (hemoglobin A1c) and incident venous thromboembolism in the Atherosclerosis Risk in Communities cohort study.
    Bell EJ; Selvin E; Lutsey PL; Nambi V; Cushman M; Folsom AR
    Vasc Med; 2013 Oct; 18(5):245-50. PubMed ID: 24165467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum levels of vitamin D are not associated with future risk of venous thromboembolism. The Tromsø Study.
    Brodin E; Lerstad G; Grimnes G; Brækkan SK; Vik A; Brox J; Svartberg J; Jorde R; Hansen JB
    Thromb Haemost; 2013 May; 109(5):885-90. PubMed ID: 23446951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective Study of Endogenous Hormones and Incidence of Venous Thromboembolism: The Atherosclerosis Risk in Communities Study.
    Roetker NS; MacLehose RF; Hoogeveen RC; Ballantyne CM; Basu S; Cushman M; Folsom AR
    Thromb Haemost; 2018 Nov; 118(11):1940-1950. PubMed ID: 30296818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Citrullinated histone H3, a biomarker of neutrophil extracellular trap formation, predicts the risk of venous thromboembolism in cancer patients.
    Mauracher LM; Posch F; Martinod K; Grilz E; Däullary T; Hell L; Brostjan C; Zielinski C; Ay C; Wagner DD; Pabinger I; Thaler J
    J Thromb Haemost; 2018 Mar; 16(3):508-518. PubMed ID: 29325226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of incident myocardial infarction on the risk of venous thromboembolism: the Tromsø Study.
    Rinde LB; Lind C; Småbrekke B; Njølstad I; Mathiesen EB; Wilsgaard T; Løchen ML; Hald EM; Vik A; Braekkan SK; Hansen JB
    J Thromb Haemost; 2016 Jun; 14(6):1183-91. PubMed ID: 27061154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.